Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Combined Modality TherapyMelphalanHematologic NeoplasmsBlood Component RemovalCyclophosphamideStem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsStem CellsHematopoietic Stem CellsGraft SurvivalBone Marrow TransplantationGraft vs Host DiseaseTreatment OutcomeBusulfanEtoposideMyeloablative AgonistsLymphoma, Non-HodgkinThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineIfosfamideSalvage TherapyHematopoiesisCord Blood Stem Cell TransplantationCytophagocytosisTissue DonorsVincristineCytarabineHodgkin DiseaseAmyloidosisDisease-Free SurvivalTransplantation ChimeraRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsHistocompatibilityBlood Cell CountInfectionPlatelet CountSurvival AnalysisHistocompatibility TestingImmunosuppressive AgentsRecombinant ProteinsDoxorubicinBlood CellsBone Marrow PurgingCytomegalovirus InfectionsLeukemia, Myeloid, AcutePOEMS SyndromeLeukemiaLymphoma, T-CellVidarabineCarboplatinTransplantation, IsogeneicLymphomaFollow-Up StudiesPrednisoneDexamethasoneEmbryonic Stem CellsFatal OutcomeAntineoplastic AgentsFeasibility StudiesProspective StudiesLeukocytes, MononuclearImmunophenotypingAdult Stem CellsGraft vs Leukemia EffectAnemia, AplasticBlood DonorsBlood Transfusion, AutologousOpportunistic InfectionsT-LymphocytesHematologic DiseasesCell SeparationMyelodysplastic SyndromesFlow CytometryLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionMesenchymal Stem Cell TransplantationBone MarrowCells, CulturedImmunomagnetic SeparationFeverCyclosporineLeukocyte CountNeutropenia